Deciphera Pharmaceuticals Inc (DCPH) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access DCPH Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Deciphera Pharmaceuticals Inc balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2024)
(Dec 31 2023) (Sep 30 2023) (Jun 30 2023) (Mar 31 2023)
Assets
Cash & cash equivalent91.23
Marketable Securities, Total MA181.30
Cash & Short-term Investments272.00
Accounts receivable32.68
Inventories0.00
Other Current Assets21.10
Prepaid Expense And Other Assets Current23.63
Total Current Assets349.94
Equipment/Property/Plant Net5.16
Long-term investments26.78
Other Assets, Noncurrent10.00
Inventory21.10
Operating Lease Right Of Use Asset30.93
Total Assets420.93
Liabilities
Accounts Payable, Current AC19.46
Accrued Liabilities And Other Liabilities60.40
Other Liabilities, Current0.00
Total Current Liabilities83.43
Total Long-term Debt0.00
Operating Lease Liability Current3.57
Operating Lease Liability Noncurrent21.45
Total Liabilities104.88
Stockholders' Equity
Common Stock Value0.82
Additional Paid In Capital Common Stock1,788.52
Retained Earnings / Accumulated Deficit-1,473.39
Other Equity0.10
Common Stockholder's Equity316.05
Total Stockholder's Equity316.05
Liabilities & Stockholder's Equity420.93
4 historic quarters locked

Sign in to unlock the full Deciphera Pharmaceuticals Inc balance sheet history.

About Deciphera Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001654151-24-000018

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.